This included a modified version of intracellular notch (ICN1-ΔRamΔP) to reduce oncogenic potential, as well as co-operating mutations such as c-Myc and TELJAK2 which are sufficient to induce leukaemia on their own and susceptible to modification of disease in the presence of aberrant notch signalling. Here, MYC is linked to leukemia.